Skip to main content
Clinical Trials/ACTRN12613000348752
ACTRN12613000348752
Completed
Phase 4

Amongst women undergoing caesarean section for placenta praevia does prophylacitc use of a Bakri intrauterine balloon immediately following delivery of placenta compared with usual measures reduce blood loss and/or the need for additional surgical/pharmacological measures to reduce blood loss

Michael Beckmann0 sites100 target enrollmentApril 2, 2013

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Michael Beckmann
Enrollment
100
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 2, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Michael Beckmann

Eligibility Criteria

Inclusion Criteria

  • All women with live singleton pregnancies \=24\+0 weeks undergoing caesarean section in the setting of a known placenta praevia (leading edge of placenta \<20mm from the cervical os) will be suitable for inclusion in this study

Exclusion Criteria

  • Multiple pregnancy
  • Intrauterine Fetal Death
  • Suspected placenta accreta
  • Congenital abnormalities of the uterine cavity
  • Submucosal uterine fibroids \>5cm
  • Women who give birth vaginally
  • Women aged \<18 years
  • Inability to consent

Outcomes

Primary Outcomes

Not specified

Similar Trials